Industry News
A new opportunity for personalizing breast cancer treatment
Jan 11, 2015
By looking at the expression levels of downstream genes of the regulators in breast cancer, investigators at Dartmouth Hitchcock's Norris Cotton Cancer Center (NCCC), led by Chao Cheng, PhD, have... Read More
Following lifestyle guidelines may reduce risk for certain cancers and for overall mortality
Jan 10, 2015
A study of nearly a half-million Americans has found that following cancer prevention guidelines from the American Cancer Society may modestly reduce your overall risk of developing cancer and have a... Read More
Chemotherapeutic natural products synthesized through selective functionalization
Jan 10, 2015
Through an extensive international collaboration, scientists at the Center for Selective C-H Functionalization (CCHF), Emory University and the Institute of Transformative Bio-Molecules (ITbM)... Read More
HPV test 'more accurate' than Pap for cervical cancer screening
Jan 09, 2015
A single test for HPV is more accurate and less costly than Pap for cervical cancer screening, according to trial results and the recommendations of a panel of experts. Read More
HPV test 'more accurate' than Pap for cervical cancer screening
Jan 09, 2015
A single test for HPV is more accurate and less costly than Pap for cervical cancer screening, according to trial results and the recommendations of a panel of experts. Read More
Oral human papillomavirus infection more likely to persist in older men
Jan 09, 2015
Oral infection with human papillomavirus 16 (HPV16), which is the type of HPV most frequently linked to HPV-driven head and neck cancers, was more likely to persist 12 or more months in men older... Read More
Scientists illuminate mysterious molecular mechanism powering cells in most forms of life
Jan 09, 2015
A team led by structural biologists at The Scripps Research Institute (TSRI) has taken a big step toward understanding the intricate molecular mechanism of a metabolic enzyme produced in most forms... Read More
Eisai is appalled by arbitrary decision to remove life-extending breast cancer therapy Halaven (eribulin) from cancer drugs fund
Jan 09, 2015
Eisai has announced its extreme disappointment that the National Cancer Drugs Fund(NCDF) panel has apparently made the decision to remove Halaven(R) (eribulin) from theCancer Drugs Fund (CDF)... Read More
Oral human papillomavirus infection more likely to persist in older men
Jan 09, 2015
Oral infection with human papillomavirus 16 (HPV16), which is the type of HPV most frequently linked to HPV-driven head and neck cancers, was more likely to persist 12 or more months in men older... Read More
Patient-centred approach to recording side effects of radiotherapy
Jan 09, 2015
For lung cancer that cannot be removed with surgery, radiotherapy is the primary treatment option. Read More
Previous Page Next Page